Literature DB >> 12771009

Neutrophil elastase in human atherosclerotic plaques: production by macrophages.

Clare M Dollery1, Caroline A Owen, Galina K Sukhova, Alexandra Krettek, Steven D Shapiro, Peter Libby.   

Abstract

BACKGROUND: Catabolism of the extracellular matrix (ECM) contributes to vascular remodeling in health and disease. Although metalloenzymes and cysteinyl proteinases have garnered much attention in this regard, the role of serine-dependent proteinases in vascular ECM degradation during atherogenesis remains unknown. We recently discovered the presence of the metalloproteinase MMP-8, traditionally associated only with neutrophils, in atheroma-related cells. Human neutrophil elastase (NE) plays a critical role in lung disease, but the paucity of neutrophils in the atheromatous plaque has led to neglect of its potential role in vascular biology. NE can digest elastin, fibrillar and nonfibrillar collagens, and other ECM components in addition to its ability to modify lipoproteins and modulate cytokine and MMP activity. METHODS AND
RESULTS: Fibrous and atheromatous plaques but not normal arteries contained NE. In particular, NE abounded in the macrophage-rich shoulders of atheromatous plaques with histological features of vulnerability. Neutrophil elastase and macrophages colocalized in such vulnerable plaques (n=7). In situ hybridization revealed NE mRNA in macrophage-rich areas, indicating local production of this enzyme. Freshly isolated blood monocytes, monocyte-derived macrophages, and vascular endothelial cells in culture produced active NE and contained NE mRNA. Monocytes produced NE constitutively, with little regulation by cytokines IL-1beta, TNF-alpha, or IFN-gamma but released it when stimulated by CD40 ligand, a cytokine found in atheroma.
CONCLUSIONS: These findings point to a novel role for the serine protease, neutrophil elastase, in matrix breakdown by macrophages, a critical process in adaptive remodeling of vessels and in the pathogenesis of arterial diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771009     DOI: 10.1161/01.CIR.0000072792.65250.4A

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  64 in total

1.  Common coding variant in SERPINA1 increases the risk for large artery stroke.

Authors:  Rainer Malik; Therese Dau; Maria Gonik; Anirudh Sivakumar; Daniel J Deredge; Evgeniia V Edeleva; Jessica Götzfried; Sander W van der Laan; Gerard Pasterkamp; Nathalie Beaufort; Susana Seixas; Steve Bevan; Lisa F Lincz; Elizabeth G Holliday; Annette I Burgess; Kristiina Rannikmäe; Jens Minnerup; Jennifer Kriebel; Melanie Waldenberger; Martina Müller-Nurasyid; Peter Lichtner; Danish Saleheen; Peter M Rothwell; Christopher Levi; John Attia; Cathie L M Sudlow; Dieter Braun; Hugh S Markus; Patrick L Wintrode; Klaus Berger; Dieter E Jenne; Martin Dichgans
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-06       Impact factor: 11.205

2.  Distinct infiltration of neutrophils in lesion shoulders in ApoE-/- mice.

Authors:  Pierre Rotzius; Sebastian Thams; Oliver Soehnlein; Ellinor Kenne; Chi-Nan Tseng; Niklas K Björkström; Karl-Johan Malmberg; Lennart Lindbom; Einar E Eriksson
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

3.  Protease Activity in Vascular Disease.

Authors:  Megan A Slack; Scott M Gordon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-25       Impact factor: 8.311

4.  Liberation of desmosine and isodesmosine as amino acids from insoluble elastin by elastolytic proteases.

Authors:  Hideyuki Umeda; Masanori Aikawa; Peter Libby
Journal:  Biochem Biophys Res Commun       Date:  2011-06-25       Impact factor: 3.575

5.  Rosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory Properties.

Authors:  Scott M Gordon; Benjamin McKenzie; Georgina Kemeh; Maureen Sampson; Shira Perl; Neal S Young; Michael B Fessler; Alan T Remaley
Journal:  Mol Cell Proteomics       Date:  2015-10-19       Impact factor: 5.911

6.  Quantification of desmosine and isodesmosine using MALDI-ion trap tandem mass spectrometry.

Authors:  Pratikkumar Rathod; Manjeet Kaur; Hsin-Pin Ho; Marissa E Louis; Basant Dhital; Philip Durlik; Gregory S Boutis; Kevin J Mark; Jong I Lee; Emmanuel J Chang
Journal:  Anal Bioanal Chem       Date:  2018-07-31       Impact factor: 4.142

Review 7.  Secretory leukocyte protease inhibitor promising protective roles in obesity-associated atherosclerosis.

Authors:  Qiao-Qing Zhong; Xiang Wang; Yun-Feng Li; Li-Jun Peng; Zhi-Sheng Jiang
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

Review 8.  Innate and adaptive immunity in atherosclerosis.

Authors:  René R S Packard; Andrew H Lichtman; Peter Libby
Journal:  Semin Immunopathol       Date:  2009-05-16       Impact factor: 9.623

Review 9.  Vascular pathology in the aged human brain.

Authors:  Lea Tenenholz Grinberg; Dietmar Rudolf Thal
Journal:  Acta Neuropathol       Date:  2010-02-14       Impact factor: 17.088

10.  Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction.

Authors:  Koichi Kaikita; Takanori Hayasaki; Toshiyuki Okuma; William A Kuziel; Hisao Ogawa; Motohiro Takeya
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.